Maintain BUY, TP: RM5.94. With more plans unveiled on its “vaccine foray”, coupled with strong sentiment on such plays, we raise our PE target from 18x (+1SD to 5 year mean) to 21.5x (+2SD). This raises our TP from RM4.95 to RM5.94. We maintain BUY. Our TP is derived from P/E target of 21.5x (+2SD above 5 year mean) pegged to mid FY21 EPS.
Source: Hong Leong Investment Bank Research - 25 Aug 2020
I just want let everyone see your behaviour, wish others dont trust on you this bluff king, thick face king, my little dog!
---------------------------------------------------------------------------------------------------------------------------- pang72 john1102 @pang72, lets see tomorrow.. if no limit up, then you will let me laugh.. haha.. keep my word.. will see who are bluff king tomorrow.. 24/08/2020 8:10 PM john1102 sell on news.. tomorrow will drop more... 24/08/2020 6:35 PM
OK! LET'S SEE! I KEEP YOUR WORD! 24/08/2020 8:14 PM
The vaccines mentioned by Khairy are the ones by Sinopharm.
Titijaya has formal agreement with Sinopharm, once the vaccines are final approved. Titijaya as the partner of Sinopharm in Malaysia, according to the agreement, Titijaya has the right to distribute the medical product to Indonesia, Thailand, Singapore, Australia and Malaysia.
OK, Kossai just announced their QR. Still remember what happened when Suparman released their RECORD quarter profit lately? BOOM! Almost LIMIT DOWN in A DAY from RM24 (Sky diving).
Wah ......what happen to pharma only up +0.69 and closed 5.96 ?? ta la Cantik, ta la Cantik, ta la Cantik.
Sudah cukup profit buyer can turun kereta..... Belum cukup profit buyer dan mahu dipaksa -paksa profit like TG ... go for 2nd round buying
Beginning of Aug 2020, big boys star reducing their fund slowly from glove, How??? By Upgrading glove target to RM50...RM100
Like usual, I know big boys tail (ekor) curi -curi sini, curi curi sana , wayang here ...wayang there ..
exactly like TG during price on 24 Feb 2020 wolf story : Dont buy, downgrade, gap down ,shake out ...
=============================== Stock: [TOPGLOV]: TOP GLOVE CORP BHD Feb 24, 2020 10:07 AM | Report Abuse
tut tut 4.5 ( 3 times hard core wolf story start... very soft,kind and caring) -----> super sonic power to block other buyer join (superman story) -----> rm15 ( tutle story) -----> near rm 30 ( grand mother story)
No more deeeeeeep discounted on price for pharma , dpharma .... Why ? less buyer willing to sell once confirmed BREAKOUT. Big boy block and lock share price before hijack to next level Only Buy on pullback. Big boy will use high speed Up n Down to shake out weak holder.
Expected BIGGGG selling pressure on glove counters from now till Sep 2020.
Big Boy average cost as below: TG rm 15 -- Rm 17 Supermx rm 9 --- RM 12
Vaccine trial is not 100% ready but countries are taking chances. Half is better than none. Look at US, UK, Russia and China all speeding up and get the vaccine doses available before year end. Even WHO will issue emergency greenlight for the trial dosage usage.
Pharmaceutical companies are the real beneficiary of the covid 19 outbreak epidemic. Vaccine , medicals , syringes are all needed and stock up by health authorities. Government will buy in bulk and distributed it thru their state owned companies
Glovers believe that healthcare is all about using Gloves ONLY. Therefore, they have a strong perception bias in believing that Pharmaniaga and Duopharma are all about Vaccine only, while ignoring the fact that the higher the anticipation of public/investors towards covid vaccine, the less interested they are in glove counters - which is justifiable by simultaneous downward trend for gloves and upward trend for pharmaceutical counters.
On the other hand, investor's appetite for Pharmaceutical counters won't wear off easily like that happen in gloves. The problem with gloves are that higher than usual glove demands is not sustainable in the long run - same does the ASP - due to foreseeable downward pressure on ASP as a result of more and more competitors joining the bandwagon.
Gloves are suffering too much internal and external pressure. Competitions, Supply shortage, labor shortage etc. Coupled with rumours on Vaccine as glove killer, windfall tax and over-weighted share prices.
Hmm i think i will further wait. If glove is coming back in two days that means vaccine will be panic sell due to mostly here are ikan bilis. Tends to kepala pusing to the wind where it blows
like i said.... GORENG only without fundamental.. as if Pharmaniaga is producing vaccine... lolz... not sure what profit you're talking about... now all SELLING and running away... as i informed yesterday, all kena burn today
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,510 posts
Posted by pang72 > 2020-08-25 22:38 | Report Abuse
Hihi...
Sour grape detected.
I ignore..
Everyone please learn